BR9804582A - Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos. - Google Patents

Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos.

Info

Publication number
BR9804582A
BR9804582A BR9804582-2A BR9804582A BR9804582A BR 9804582 A BR9804582 A BR 9804582A BR 9804582 A BR9804582 A BR 9804582A BR 9804582 A BR9804582 A BR 9804582A
Authority
BR
Brazil
Prior art keywords
compounds
well
benzoazepinone
processes
preparation
Prior art date
Application number
BR9804582-2A
Other languages
English (en)
Inventor
Harald Waldeck
Joerg Meil
Dirk Thormaehlen
Michael Wurl
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BR9804582A publication Critical patent/BR9804582A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção:<B>"DERIVADOS DE áCIDO BENZOAZEPINONA-N-ACéTICO SUBSTITUìDOS POR áCIDOS FOSFÈNICOS, ASSIM COMO PROCESSOS PARA A SUA PREPARAçãO E MEDICAMENTOS QUE CONTêM ESTES COMPOSTOS"<D>. São descritos compostos eficazes como inibidores da endopeptidase neutral (NEP), de fórmula geral I na qual R^ 1^ representa hidrogênio ou um grupo que forme um fosfonato biologicamente instável, R^ 2^representa hidrogênio ou um grupo que forme um fosfonato biologicamente instável, R^ 3^ representa hidrogênio ou um grupo que forme um carbonato biologicamente instável, e os sais fisiologicamente aceitáveis dos ácidos de fórmula I, assim como medicamentos que contêm estes compostos.
BR9804582-2A 1997-11-12 1998-11-11 Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos. BR9804582A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19750002A DE19750002A1 (de) 1997-11-12 1997-11-12 Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
BR9804582A true BR9804582A (pt) 2000-05-09

Family

ID=7848410

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9804582-2A BR9804582A (pt) 1997-11-12 1998-11-11 Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos.

Country Status (28)

Country Link
US (1) US5952327A (pt)
EP (1) EP0916679B1 (pt)
JP (1) JP4162780B2 (pt)
KR (1) KR19990045100A (pt)
CN (1) CN1187361C (pt)
AR (1) AR009911A1 (pt)
AT (1) ATE228144T1 (pt)
AU (1) AU746907B2 (pt)
BR (1) BR9804582A (pt)
CA (1) CA2253997C (pt)
CZ (1) CZ296123B6 (pt)
DE (2) DE19750002A1 (pt)
DK (1) DK0916679T3 (pt)
DZ (1) DZ2652A1 (pt)
ES (1) ES2186961T3 (pt)
HK (1) HK1019338A1 (pt)
HU (1) HU221177B1 (pt)
ID (1) ID21393A (pt)
IL (1) IL126984A (pt)
NO (1) NO317640B1 (pt)
NZ (1) NZ332744A (pt)
PL (1) PL191436B1 (pt)
PT (1) PT916679E (pt)
RU (1) RU2211219C2 (pt)
SK (1) SK283233B6 (pt)
TR (1) TR199802289A3 (pt)
UA (1) UA60304C2 (pt)
ZA (1) ZA9810316B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL367093A1 (en) * 2001-05-18 2005-02-21 Solvay Pharmaceuticals Gmbh Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
WO2003059939A1 (en) * 2002-01-16 2003-07-24 Solvay Pharmaceuticals B.V. Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
CL2004000544A1 (es) * 2003-03-18 2005-01-28 Pharmacia Corp Sa Organizada B Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7427611B2 (en) * 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
US7232813B2 (en) * 2004-01-12 2007-06-19 Solvay Pharmaceuticals B.V. Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders
WO2005067937A1 (en) * 2004-01-12 2005-07-28 Solvay Pharmaceuticals B.V. Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
US7816347B2 (en) 2004-12-15 2010-10-19 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
WO2007102171A2 (en) * 2006-03-07 2007-09-13 Panacea Biotec Ltd Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition
US8198341B2 (en) 2008-12-18 2012-06-12 Icl-Ip America Inc. Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
EP2909218B1 (en) 2012-10-17 2019-07-10 ICL-IP America Inc. Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
US9528269B2 (en) 2014-06-09 2016-12-27 Johns Manville Roofing systems and roofing boards with non-halogenated fire retardant
US9815256B2 (en) 2014-06-09 2017-11-14 Johns Manville Foam boards including non-halogenated fire retardants
US9523195B2 (en) 2014-06-09 2016-12-20 Johns Manville Wall insulation boards with non-halogenated fire retardant and insulated wall systems
US9815966B2 (en) 2014-07-18 2017-11-14 Johns Manville Spray foams containing non-halogenated fire retardants
CN107383084A (zh) * 2017-06-14 2017-11-24 浙江嘉华化工有限公司 一种0‑乙基磷酸钠的制备方法
PL424453A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)
PL424452A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors

Also Published As

Publication number Publication date
DE59806345D1 (de) 2003-01-02
PT916679E (pt) 2003-03-31
NO317640B1 (no) 2004-11-29
TR199802289A2 (xx) 1999-06-21
CA2253997A1 (en) 1999-05-12
ID21393A (id) 1999-06-03
NO985262D0 (no) 1998-11-11
AU9234498A (en) 2000-06-08
ES2186961T3 (es) 2003-05-16
CZ356298A3 (cs) 1999-06-16
EP0916679A1 (de) 1999-05-19
DK0916679T3 (da) 2002-12-16
CA2253997C (en) 2009-05-12
TR199802289A3 (tr) 1999-06-21
IL126984A (en) 2001-07-24
PL329635A1 (en) 1999-05-24
HUP9802517A3 (en) 2000-06-28
NO985262L (no) 1999-05-14
HK1019338A1 (en) 2000-02-03
PL191436B1 (pl) 2006-05-31
ATE228144T1 (de) 2002-12-15
UA60304C2 (uk) 2003-10-15
DE19750002A1 (de) 1999-05-20
JP4162780B2 (ja) 2008-10-08
HU221177B1 (en) 2002-08-28
RU2211219C2 (ru) 2003-08-27
HUP9802517A2 (hu) 1999-09-28
EP0916679B1 (de) 2002-11-20
SK151698A3 (en) 1999-05-07
US5952327A (en) 1999-09-14
NZ332744A (en) 2000-06-23
AU746907B2 (en) 2002-05-02
HU9802517D0 (en) 1998-12-28
DZ2652A1 (fr) 2003-03-15
CN1187361C (zh) 2005-02-02
CN1217334A (zh) 1999-05-26
AR009911A1 (es) 2000-05-03
JPH11292886A (ja) 1999-10-26
SK283233B6 (sk) 2003-04-01
ZA9810316B (en) 1999-05-18
CZ296123B6 (cs) 2006-01-11
IL126984A0 (en) 1999-09-22
KR19990045100A (ko) 1999-06-25

Similar Documents

Publication Publication Date Title
BR9804582A (pt) Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos.
BR9912188A (pt) Derivados de 1,1-dióxido de benzo (b) tiepina, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação
BR9915967A (pt) Derivados de propanolamina substituìdos por arila, proceso para sua preparação, medicamentos contendo estes compostos e seu uso
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BR0116482A (pt) Derivados de difenilazetidinona, processo para a preparação, medicamentos contendo esses compostos e seu emprego.
PT1027037E (pt) Composicao farmaceutica que compreende clodronato como ingredientes activo e celulose microcristalina silicificada como excipiente
BR0111457A (pt) Derivados de acilfeniluréia, processos para a sua preparação e sua aplicação como medicamentos
AR014417A1 (es) LA SAL DE BISULFATO DEL ÉSTER DIMETíLICO DEL ÁCIDO[3S- (3R*, 8&#39;R*, 9&#39;R*, 12R*)] -3,12-BIS (1,1-DIMETILETIL) -8- HIDROXI-4,11- DIOXO-9- (FENILMETIL) -6- [[4-(2-PIRIDINIL) -FENILMETIL]] -2,5,6,10,13- PENTAAZATETRADECANODIOICO Y LA COMPOSICIoN FARMACÉUTICA QUE LA CONTIENE
TR199500825A2 (tr) Cok üniteli farmasötik müstahzar.
BR9915403A (pt) Antagonistas receptores iii de 4-aroil-piperidin-ccr-3
BR0210285A (pt) Utilização de um composto, composto e composição farmacêutica
BR9915735A (pt) Antagonistas receptores de ccr-3 de piperidina
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR9912921A (pt) Processos para a preparação de n- (fosfonometil) glicina, de um sal de n- (fosfonometil) glicina, ou de um éster de n- (fosfonometil) glicina, para a preparação de uma n- (fosfonometil) glicina substituìda em n ou um seu sal, e para a preparação de uma monoetanolamina substituìda em n, e, catalisador de oxidação
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
BR9809492A (pt) Composição farmacêutica aquosa injetável, e, processo para a preparação da mesma
BR9908458A (pt) Tiolésteres de ácido 11beta-benzaldoxim-estra-4,9-dien-carbÈnico substituìdos por s, processos para a sua preparação e preparados farmacêuticos contendo estes compostos
PT1051159E (pt) Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose
BR9712707A (pt) Derivados de ácido 4-bifenil-4-hidroxibutìrico substituìdo com inibidores de metaloprotease de matriz
DK440888A (da) Hjaelpestoffer som resorptionsfremmende stoffer af peptider og proteiner ved paafoering paa slimhinder samt anvendelse deraf g praepparat indeholdende hjaelpestofferne
BR0106248A (pt) Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos
BR9804485A (pt) Compostos de indanol, processo para sua preparação e composições farmacêuticas contendo os mesmos.
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/11/1998, OBSERVADAS AS CONDICOES LEGAIS.

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 14A ANUIDADE, CONFORME ART. 87 DA LPI 9.279.

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.